When That Little Finger Clip Lies: Why Pulse Oximetry Gets It Wrong in COPD Smokers

Introduction

As a respiratory physician, I've witnessed countless situations where that trusty little device clipped to a patient's finger delivers readings that just don't match clinical reality. Today, I want to share insights from our research presented at the European Respiratory Society Congress in Vienna (2012), which uncovered a fascinating and clinically significant problem: pulse oximetry can be misleading in COPD patients who smoke.

The Problem: When SpO2 Doesn't Equal SaO2

Pulse oximeters are ubiquitous in modern medicine. They're quick, non-invasive, and seemingly reliable. But here's the catch: what they measure (SpO2) isn't always what we think it measures (SaO2).

Our study investigated whether peripheral oxygen saturation measured by pulse oximetry (SpO2) accurately reflects arterial oxygen saturation (SaO2) measured by arterial blood gas analysis in stable COPD patients. The results were eye-opening.

The Study Design

We examined stable COPD outpatients at St. Helens and Knowsley Teaching Hospitals NHS Trust. For each patient, we simultaneously measured:

• SpO2 using standard pulse oximetry
• SaO2 using arterial blood gas analysis (the gold standard)

We also collected data on:

• Smoking status
• Carbon monoxide (CO) levels
• Carboxyhaemoglobin (COHb) levels

Key Findings: The Smoking Factor

1. The Overall Mismatch

In stable COPD patients, particularly those who smoke, pulse oximetry consistently overestimated oxygen saturation. The readings looked reassuringly normal when the actual arterial oxygen levels told a different story.

2. The Carbon Monoxide Connection

The mechanism became clearer when we examined carbon monoxide levels. Smokers had elevated COHb levels, and this was the key to understanding the discrepancy.

Here's why it matters:

• Carboxyhaemoglobin (COHb) is haemoglobin bound to carbon monoxide
• COHb has a similar light absorption spectrum to oxyhaemoglobin
• Standard pulse oximeters can't distinguish between them
• The device reads COHb as if it were oxygenated blood
• Result: falsely elevated oxygen saturation readings

3. Clinical Implications

The implications for patient care are significant:

For COPD Smokers:

• Pulse oximetry alone may provide false reassurance
• Patients may appear more stable than they actually are
• Treatment decisions based solely on SpO2 could be inappropriate
• Arterial blood gas analysis remains essential for accurate assessment

For Emergency Situations:

• In acute COPD exacerbations in smokers, don't rely solely on pulse oximetry
• Consider the patient's smoking history when interpreting oxygen saturation
• Factor in recent smoking when assessing respiratory status
• When in doubt, obtain arterial blood gas measurements

The Science: Why COHb Fools the Oximeter

Let me explain the photometric principle that leads to this problem:

Normal Pulse Oximetry

Standard pulse oximeters use two wavelengths of light:

• 660 nm (red light) - absorbed differently by deoxygenated haemoglobin
• 940 nm (infrared light) - absorbed differently by oxygenated haemoglobin

The ratio of absorption at these wavelengths allows the device to calculate oxygen saturation.

The COHb Problem

Carboxyhaemoglobin absorbs light at 660 nm in a similar pattern to oxygenated haemoglobin. The oximeter's algorithm wasn't designed to account for this interference, leading to:

• Overestimation of true oxygen saturation
• The greater the COHb level, the greater the overestimation
• Particularly problematic in active smokers with COPD

Practical Recommendations for Clinicians

Based on our research and clinical experience, here are my recommendations:

1. Know Your Patient Population

High-risk groups for inaccurate SpO2:

• Active smokers with COPD
• Recent ex-smokers (within hours of last cigarette)
• Patients with carbon monoxide exposure
• Those living in high-pollution environments

2. When to Be Skeptical of Pulse Oximetry

Be particularly cautious when:

• The patient is a known smoker but SpO2 appears normal
• Clinical presentation doesn't match the oximetry reading
• The patient looks dyspneic but SpO2 is >94%
• There's a recent history of heavy smoking

3. When to Obtain Arterial Blood Gases

Consider ABG analysis in:

• Acute COPD exacerbations in smokers
• When SpO2 seems inconsistent with clinical picture
• Before making decisions about oxygen therapy
• When assessing eligibility for long-term oxygen therapy
• During hospitalization for respiratory failure

4. Consider Co-oximetry

For the most accurate assessment in smokers:

• Use co-oximetry when available
• Co-oximeters can directly measure COHb levels
• They provide true oxygen saturation independent of COHb
• Particularly useful in smoking cessation clinics

Implications for Oxygen Therapy

This research has important implications for oxygen prescription:

Long-Term Oxygen Therapy (LTOT) Assessment

• LTOT eligibility is typically based on arterial oxygen levels
• Pulse oximetry alone should not be used to assess LTOT candidacy
• In smokers, SpO2 may suggest oxygen isn't needed when it actually is
• Always use formal ABG analysis for LTOT assessment

Acute Oxygen Therapy Titration

• In emergency settings, don't rely solely on pulse oximetry in smokers
• Target saturations may be misleading
• Regular ABG monitoring is essential
• Be aware that the "safe" 88-92% target in COPD may not be what the pulse oximeter suggests

The Research Context: ERS Vienna 2012

Our study was part of a broader body of work examining the reliability of pulse oximetry in different clinical scenarios. Key points from our presentation:

Study Details:

• Authors: Rajesh Kumar Yadavilli, Vinay Shanker, Sreeguru Lakshman, Paul Stockton, Simon Twite, Sanjeev Agarwal
• Institution: Respiratory Medicine, St. Helens and Knowsley Teaching Hospitals NHS Trust, Prescot, United Kingdom
• Conference: ERS International Congress, Vienna, Austria
• Date: September 1-5, 2012

The research added to the growing evidence that we need to be more critical in our use of pulse oximetry, particularly in specific patient populations.

Looking Forward: Better Monitoring Technologies

Since our Vienna presentation, there have been developments in oximetry technology:

Advanced Pulse Oximeters

• Some newer devices can measure COHb levels
• Multi-wavelength oximeters provide more accurate readings
• Trending capabilities help identify discrepancies
• Integration with electronic health records improves clinical decision-making

Point-of-Care Testing

• Portable ABG analyzers becoming more accessible
• Faster turnaround times for blood gas results
• Reduced need for arterial puncture with some technologies
• Better integration of monitoring in community settings

Clinical Pearls: What I Tell My Trainees

After years of managing COPD patients, here's what I emphasize:

1. The Clinical Picture Always Comes First

Never let a "normal" SpO2 override your clinical assessment:

• Is the patient dyspneic?
• What's their work of breathing?
• Are they using accessory muscles?
• What does their respiratory rate tell you?

2. Know the Patient's Smoking History

Ask specific questions:

• "When did you last smoke?"
• "How much have you smoked today?"
• "Have you been in smoky environments?"

Even "ex-smokers" who quit this morning will have elevated CO levels.

3. Trend, Don't Just Spot-Check

• A single SpO2 reading tells you little
• Watch for trends over time
• Compare with previous admissions
• Know the patient's baseline

4. When In Doubt, Check ABG

It's better to do one "unnecessary" ABG than to miss significant hypoxemia. The cost of missing true hypoxemia far outweighs the cost and minor discomfort of arterial puncture.

Conclusion: Trust, But Verify

Pulse oximetry remains an invaluable tool in respiratory medicine. It's quick, non-invasive, and generally reliable. But like all diagnostic tools, it has limitations that we must understand and respect.

In COPD patients who smoke, those limitations become clinically significant. The presence of carboxyhaemoglobin can lead to falsely reassuring oxygen saturation readings, potentially delaying necessary treatment or leading to inappropriate decisions about oxygen therapy.

The message is clear: in stable COPD smokers, pulse oximetry may lie. The little finger clip might show 95%, but the true arterial saturation could be significantly lower. When managing these patients, particularly in acute settings or when making decisions about long-term oxygen therapy, there's no substitute for arterial blood gas analysis.

As healthcare professionals, we must remain vigilant, combine our clinical acumen with appropriate diagnostic testing, and never let a single monitor reading override our comprehensive assessment of the patient.

References and Further Reading

This blog post is based on our research presented at:

• ERS International Congress 2012, Vienna, Austria
• Publication: "Does SpO2 correlate with SaO2 in stable COPD"
• Available at: European Respiratory Journal 2012; 40: Suppl. 56, P3795

Related Research

• Studies on COHb interference in pulse oximetry
• Guidelines for oxygen therapy in COPD
• Latest ERS/ATS guidelines on COPD management
• BTS guidelines on emergency oxygen use

---

Dr. Sanjeev Agarwal is a respiratory medicine consultant with extensive experience in COPD management. This article is based on research conducted at St. Helens and Knowsley Teaching Hospitals NHS Trust and presented at international medical conferences.